Mark E Prince

Author PubWeight™ 61.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008 5.46
2 Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 2008 3.55
3 Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010 2.76
4 Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 2010 2.41
5 Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010 2.11
6 Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004 1.91
7 Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res 2010 1.88
8 UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head Neck 2011 1.45
9 Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck 2011 1.35
10 Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Res 2008 1.35
11 Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys 2011 1.33
12 Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys 2007 1.31
13 Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int J Radiat Oncol Biol Phys 2008 1.24
14 HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck 2010 1.23
15 Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status. Head Neck 2012 1.18
16 Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope 2009 1.17
17 The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys 2009 1.10
18 Disability in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004 1.10
19 Head and neck cancer stem cells: the side population. Laryngoscope 2010 0.98
20 Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors. Head Neck 2013 0.98
21 Rectangle tongue template for reconstruction of the hemiglossectomy defect. Arch Otolaryngol Head Neck Surg 2008 0.96
22 Restoration of the orbital aesthetic subunit in complex midface defects. Laryngoscope 2004 0.95
23 Variables associated with feeding tube placement in head and neck cancer. Arch Otolaryngol Head Neck Surg 2006 0.94
24 Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2008 0.94
25 The role of head and neck squamous cell carcinoma cancer stem cells in tumorigenesis, metastasis, and treatment failure. Front Endocrinol (Lausanne) 2012 0.94
26 Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells. Stem Cells 2014 0.93
27 Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer. Int J Radiat Oncol Biol Phys 2007 0.93
28 High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma. Transl Oncol 2010 0.92
29 Thoracodorsal artery scapular tip autogenous transplant: vascularized bone with a long pedicle and flexible soft tissue. Arch Otolaryngol Head Neck Surg 2010 0.91
30 Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro. Mol Pharm 2010 0.90
31 Head and neck cancer stem cells: the effect of HPV--an in vitro and mouse study. Otolaryngol Head Neck Surg 2013 0.89
32 Osseocutaneous radial forearm free tissue transfer for repair of complex midfacial defects. Arch Otolaryngol Head Neck Surg 2005 0.88
33 Improved outcomes in patients with head and neck cancer using a standardized care protocol for postoperative alcohol withdrawal. Arch Otolaryngol Head Neck Surg 2008 0.88
34 Reconstruction of complex parotidectomy defects using the lateral arm free tissue transfer. Otolaryngol Head Neck Surg 2003 0.87
35 Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma. Head Neck 2014 0.87
36 Cartilaginous tumours of the larynx. J Otolaryngol 2003 0.86
37 Skin cancer of the head and neck with perineural invasion: defining the clinical target volumes based on the pattern of failure. Int J Radiat Oncol Biol Phys 2008 0.86
38 Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer. Head Neck 2012 0.85
39 Lateral oromandibular defect: when is it appropriate to use a bridging reconstruction plate combined with a soft tissue revascularized flap? Head Neck 2008 0.83
40 Radial forearm free tissue transfer reduces complications in salvage skull base surgery. Otolaryngol Head Neck Surg 2004 0.83
41 Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor. Head Neck 2014 0.82
42 Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer. Head Neck 2013 0.81
43 Epidermal growth factor receptor, p16, cyclin D1, and p53 staining patterns for inverted papilloma. Int Forum Allergy Rhinol 2013 0.81
44 In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells. Otolaryngol Head Neck Surg 2013 0.81
45 Chemotherapy alone for organ preservation in advanced laryngeal cancer. Head Neck 2010 0.79
46 End-of-life care among head and neck cancer patients. Otolaryngol Head Neck Surg 2011 0.78
47 Head and neck squamous cell carcinoma in pregnant women. Head Neck 2012 0.78
48 Improving end-of-life care for head and neck cancer patients. Expert Rev Anticancer Ther 2012 0.77
49 Association Between Multimodality Neck Treatment and Work and Leisure Impairment: A Disease-Specific Measure to Assess Both Impairment and Rehabilitation After Neck Dissection. JAMA Otolaryngol Head Neck Surg 2015 0.76
50 Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. ORL J Otorhinolaryngol Relat Spec 2016 0.75
51 Prospective head and neck cancer research: a four-decade bibliometric perspective. Oncologist 2013 0.75
52 Videofluoroscopic-guided botulinum toxin injections for pharyngoesophageal spasm after total laryngectomy. Laryngoscope 2013 0.75
53 Revascularized tissue transplant and internal transport disk distraction osteogenesis for the reconstruction of complex composite mandibular defects. J Otolaryngol Head Neck Surg 2011 0.75
54 An unusual thyroglossal duct cyst infection with coccidioidomycosis. J Otolaryngol 2007 0.75
55 Successful multimodal treatment of a carcinosarcoma of the masticator space. J Otolaryngol 2007 0.75
56 Familial Zenker's diverticulum: case study and historical perspective. J Otolaryngol 2005 0.75
57 Oropharyngoplasty with template-based reconstruction of oropharynx defects. Arch Otolaryngol Head Neck Surg 2009 0.75
58 When negative rights become positive entitlements: complicity, conscience, and caregiving. J Clin Ethics 2012 0.75